Volume: 3 Issue: 3
Year: 2015, Page: 1-5,
Objective: : Emphysematous pyelonephritis (EPN) is a severe, necrotizing infection of the renal parenchyma; it causes gas formation within the collecting system, renal parenchyma, and/or perirenal tissues . Gas in the renal pelvis alone, without parenchymal gas, is often referred to as emphysematous pyelitis. The main objective of this study is to elucidate the clinical features,radiological classification, prognostic factors of Emphysematous pyelonephritis , to compare the modalities of management and outcomes among various radiological classes of EPN.
Materials & Methods: The present study was conducted among the patients who were admitted between September 2013 to September 2015. 34 consecutive cases diagnosed as EPN were included in the study. The baseline characteristics , laboratory data, abdominal CT scan was taken. Based on CT scan staging , HDN/HDUN/collection was managed with PCN/DJ stenting/ PCD/nephrectomy and results noted.
Results: The mean age of our patients was 55 years , with a male to female ratio of 1.2:1. The most common predisposing factor was diabetes (28 cases-82%) followed by urolithiasis. Right side (50%) was more commonly affected than left (35.3%). Five patients (11.7%) had bilateral involvement and one had EPN of solitary kidney (2.9%). 2 patients (6%) received antibiotics alone , four (12%) had an early nephrectomy , 25 (73%) received PCD/PCN/DJ stenting alone and 3(9%) had delayed nephrectomy after initial PCD.
Conclusion: Traditionally EPN is associated with high mortality, but presently the mortality rates seem to be reducing because of improved staging modalities and effective antibiotics /PCD/PCN/DJ stenting.Identification of prognostic factors may stratify patients for conservative or surgical management.In the era of effective antibiotics & interventional radiology the threshold for early nephrectomy should be high, which is associated with high mortality.
Keywords: Emphysematous pyelonephritis, nephrectomy, necrotizing infection, renal parenchyma.
1. Michaeli J, Mogle P, Perlberg Set al.Emphysematouspyelonephritis.JUrol1984;13: 203–8.
2. Kelly HA, MacCullum WG. Pneumaturia. JAMA. 1898;31:375-81.
3. JJ Tseng CC: Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 160(6):797-805.
4. Shokeir AA, El-Azab M, Mohsen T, El-Diasty T: Emphysematous pyelonephritis: a 15-year experience with 20 cases.
5. Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, Skinner DG: Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol 1985, 134(6):1086-8.
6. Wang JM, Lim HK, Pang KK: Emphysematous pyelonephritis. Scand J Urol Nephrol 2007, 41(3):223-9.
7. Christensen J, Bistrup C: Case report: emphysematous pyelonephritis caused by clostridium septicum and complicated by a mycotic aneurysm. Br J Radiol 1993, 66(789):842-3.
8. Cheng YT, Wang HP, Hsieh HH. Emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and nephrostomy. Clin Transplant. Oct 2001;15(5):364-7.
9. Tseng CC, Wu JJ, Wang MC, Hor LI, Ko YH, Huang JJ: Host and bacterial virulence factors predisposing to emphysematous pyelonephritis. Am J Kidney Dis 2005, 46(3):432- 9.
10. Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY: Predictors of outcome in emphysematous pyelonephritis. J Urol 1998, 159(2):369-73.
11. Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II: Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol 2007, 178(3 Pt 1):880-5. quiz 1129
Tyagi A,Venkat reddy K,Bhargava K V,Jayaraju J,Lokesh,Ramprasad A. Management and Outcomes of Emphysematous Pyelonephritis – A study of 34 cases. Perspectives in medical research 2015;3:3:1-5.